{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Vascular&page=9", "query": { "condition": "Vascular", "page": 9 }, "page_size": 10 }, "pagination": { "page": 9, "page_size": 10, "total_count": 15039, "total_pages": 1504, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Vascular&page=10&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Vascular&page=8&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T01:36:08.848Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01328769", "title": "Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Febuxostat", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Paul N. Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 49, "start_date": "2011-03", "completion_date": "2014-01", "has_results": true, "last_update_posted_date": "2015-09-17", "last_synced_at": "2026-11-15T01:36:08.848Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT01328769" }, { "nct_id": "NCT00471341", "title": "Effect of Celecoxib on Markers of Vascular Inflammation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension and Coronary Artery Disease" ], "interventions": [ { "name": "Celecoxib", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 75, "start_date": "2002-07", "completion_date": "2004-12", "has_results": false, "last_update_posted_date": "2011-09-19", "last_synced_at": "2026-11-15T01:36:08.848Z", "location_count": 2, "location_summary": "Gainesville, Florida • Houston, Texas", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00471341" }, { "nct_id": "NCT00476294", "title": "Long-Term Follow Up Study for AMD3100 Patients", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Myeloma" ], "interventions": [ { "name": "Telephone Questionnaire", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "78 Years", "sex": "ALL", "summary": "18 Years to 78 Years" }, "enrollment_count": 7, "start_date": "2006-10", "completion_date": "2012-07", "has_results": false, "last_update_posted_date": "2012-07-11", "last_synced_at": "2026-11-15T01:36:08.848Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00476294" }, { "nct_id": "NCT04082520", "title": "Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Grade 1 Meningioma", "Grade 2 Meningioma", "Grade 3 Meningioma", "Recurrent Meningioma", "Unresectable Meningioma" ], "interventions": [ { "name": "Gallium Ga 68-DOTATATE", "type": "RADIATION" }, { "name": "Lutetium Lu 177 Dotatate", "type": "DRUG" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Single Photon Emission Computed Tomography", "type": "PROCEDURE" } ], "intervention_types": [ "RADIATION", "DRUG", "PROCEDURE", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 42, "start_date": "2020-04-14", "completion_date": "2032-03-04", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-11-15T01:36:08.848Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04082520" }, { "nct_id": "NCT00000623", "title": "Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Anemia, Cooley's", "Beta-Thalassemia", "Hematologic Diseases", "Thalassemia", "Osteoporosis", "Iron Overload", "Hypertension, Pulmonary" ], "interventions": [ { "name": "Deferoxamine", "type": "DRUG" }, { "name": "Deferiprone", "type": "DRUG" }, { "name": "Arginine", "type": "DRUG" }, { "name": "Sildenafil", "type": "DRUG" }, { "name": "Decitabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Carelon Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "75 Years", "sex": "ALL", "summary": "1 Year to 75 Years" }, "enrollment_count": 1000, "start_date": "2000-07", "completion_date": "2006-07", "has_results": false, "last_update_posted_date": "2014-03-04", "last_synced_at": "2026-11-15T01:36:08.848Z", "location_count": 4, "location_summary": "Oakland, California • Boston, Massachusetts • New York, New York + 1 more", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000623" }, { "nct_id": "NCT04843579", "title": "Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Myeloma Multiple", "Myeloma", "Refractory Multiple Myeloma" ], "interventions": [ { "name": "Selinexor", "type": "DRUG" }, { "name": "Clarithromycin", "type": "DRUG" }, { "name": "Pomalidomide", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 4, "start_date": "2021-12-29", "completion_date": "2022-12-30", "has_results": true, "last_update_posted_date": "2023-10-25", "last_synced_at": "2026-11-15T01:36:08.848Z", "location_count": 2, "location_summary": "Brooklyn, New York • New York, New York", "locations": [ { "city": "Brooklyn", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04843579" }, { "nct_id": "NCT03690388", "title": "A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Differentiated Thyroid Cancer" ], "interventions": [ { "name": "Cabozantinib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Exelixis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 187, "start_date": "2018-10-05", "completion_date": "2027-07-31", "has_results": true, "last_update_posted_date": "2026-10-20", "last_synced_at": "2026-11-15T01:36:08.848Z", "location_count": 31, "location_summary": "Newport Beach, California • Sacramento, California • San Francisco, California + 27 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03690388" }, { "nct_id": "NCT01249027", "title": "XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Angioplasty", "Chronic Coronary Occlusion", "Stent Thrombosis", "Vascular Disease", "Myocardial Ischemia", "Coronary Artery Stenosis", "Coronary Disease", "Coronary Artery Disease", "Coronary Restenosis" ], "interventions": [ { "name": "XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Abbott Medical Devices", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 2605, "start_date": "2010-11", "completion_date": "2017-01", "has_results": true, "last_update_posted_date": "2019-03-01", "last_synced_at": "2026-11-15T01:36:08.848Z", "location_count": 1, "location_summary": "Santa Clara, California", "locations": [ { "city": "Santa Clara", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01249027" }, { "nct_id": "NCT03516656", "title": "Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Deep Vein Thrombosis", "Pulmonary Embolism", "Venous Thromboembolism" ], "interventions": [ { "name": "Standard heparin dose", "type": "DRUG" }, { "name": "Real time heparin dose adjustment", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2018-03-23", "completion_date": "2021-08-24", "has_results": false, "last_update_posted_date": "2023-05-17", "last_synced_at": "2026-11-15T01:36:08.848Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT03516656" }, { "nct_id": "NCT02085551", "title": "Case Review of the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Peripheral Arterial Occlusion or Emboli" ], "interventions": [ { "name": "Mechanical Thrombectomy by the Indigo System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Penumbra Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 85, "start_date": "2014-03", "completion_date": "2015-09", "has_results": true, "last_update_posted_date": "2020-06-22", "last_synced_at": "2026-11-15T01:36:08.848Z", "location_count": 5, "location_summary": "San Diego, California • Miami, Florida • Chicago, Illinois + 2 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02085551" } ] }